Search
for
Sort by
Research 511–540 of 1000+
- Toxic shock syndrome: Recent developments in pathogenesis
- MOUSE MODELS FOR THE STUDY OF HUMAN HAIR LOSS
- Parkinson's disease and skin
- Hypersensitivity Reactions to Anticoagulant Drugs
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Skin disease in pregnancy
- Thyroid hormone action on skin.
- Nutrition and the deleterious side effects of nutritional supplements
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Medicinal Plants and their Constituents in the Treatment of Acne vulgaris
- Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach
- Drug eruptions in dermatology
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Psychotropic Medications and the Skin
- Acutely Ill Patients in Internal Medicine Departments Want Treatment for Undiagnosed, Symptomatic Skin Conditions
- What’s New in the Histologic Evaluation of Alopecia and Hair-Related Disorders?
- The eosinophilia-myalgia syndrome
- Cytokines
- Management of Toxicities of Targeted Therapies
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- Particularidades dermatológicas, fisiológicas e as dermatoses na pele negra
- The Skin and Subcutaneous Tissues
- Scarring Alopecia
- Skin Diseases in Pregnancy
- SUMMARIES OF PAPERS
- TREATMENT OF KERATOSIS PILARIS: A NARRATIVE LITERATURE REVIEW OF TOPICAL, PROCEDURAL, AND VARIANT-SPECIFIC THERAPIES
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Geriatric Dermatologic Therapy